PERSPECTA

News from every angle

← Back to headlines

Lisata Therapeutics Agrees to Kuva Labs Buyout

Lisata Therapeutics has reached an agreement for a buyout by Kuva Labs at $4 per share.

10 Jun, 13:36 — 10 Jun, 13:36
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual25d ago

Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Malaysia Considers QR Code-Enabled MyKad for Subsidised Cooking Oil Scheme

18m ago

Battery Vacuum Cleaner Deemed Europe's Most Unrepairable Device

18m ago

Nearly 15,000 New Companies Formed in Ireland This Year

18m ago